Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036572 (
seizures
)
80,221
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hereditary defects of coenzyme Q10 biosynthesis cause steroid-resistant nephrotic syndrome (SRNS) as part of multiorgan involvement but may also contribute to isolated SRNS. Here, we report 26 patients from 12 families with recessive mutations in
ADCK4
. Mutation detection rate was 1.9% among 534 consecutively screened cases. Patients with
ADCK4
mutations showed a largely renal-limited phenotype, with three subjects exhibiting occasional
seizures
, one subject exhibiting mild mental retardation, and one subject exhibiting retinitis pigmentosa.
ADCK4
nephropathy presented during adolescence (median age, 14.1 years) with nephrotic-range proteinuria in 44% of patients and advanced CKD in 46% of patients at time of diagnosis. Renal biopsy specimens uniformly showed FSGS. Whereas 47% and 36% of patients with mutations in WT1 and NPHS2, respectively, progressed to ESRD before 10 years of age, ESRD occurred almost exclusively in the second decade of life in
ADCK4
nephropathy. However, CKD progressed much faster during adolescence in
ADCK4
than in WT1 and NPHS2 nephropathy, resulting in similar cumulative ESRD rates (>85% for each disorder) in the third decade of life. In conclusion,
ADCK4
-related glomerulopathy is an important novel differential diagnosis in adolescents with SRNS/FSGS and/or CKD of unknown origin.
...
PMID:ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGS. 2596 20
Coenzyme Q
10
(CoQ
10
) or ubiquinone is one of the two electron carriers in the mitochondrial respiratory chain which has an essential role in the process of oxidative phosphorylation. Defects in CoQ
10
synthesis are usually associated with the impaired function of CoQ
10
-dependent complexes I, II and III. The recessively transmitted CoQ
10
deficiency has been associated with a number of phenotypically and genetically heterogeneous groups of disorders manifesting at variable age of onset. The infantile, multisystemic presentation is usually caused by mutations in genes directly involved in CoQ
10
biosynthesis. To date, mutations in
COQ1
(
PDSS1
and
PDSS2
),
COQ2
,
COQ4
,
COQ6
,
COQ7
,
COQ8A
/
ADCK3
,
COQ8B/
ADCK4
, and
COQ9
genes have been identified in patients with primary form of CoQ
10
deficiency. Here we report novel mutations in the
COQ4
gene, which were identified in an infant with profound mitochondrial disease presenting with perinatal
seizures
, hypertrophic cardiomyopathy and severe muscle CoQ
10
deficiency.
...
PMID:Novel recessive mutations in COQ4 cause severe infantile cardiomyopathy and encephalopathy associated with CoQ
10
deficiency. 2854 Jan 86